Loading...
XSHE
002622
Market cap400mUSD
Dec 05, Last price  
3.37CNY
1D
2.12%
1Q
-15.54%
Jan 2017
-76.89%
IPO
-22.76%
Name

Whole Shine Medical Technology Co Ltd

Chart & Performance

D1W1MN
XSHE:002622 chart
P/E
—
P/S
3.29
EPS
—
Div Yield, %
—
Shrs. gr., 5y
-0.01%
Rev. gr., 5y
40.87%
Revenues
862m
+13.86%
212,308,237358,133,211307,668,605412,528,703365,388,748244,681,605184,680,609161,042,613146,512,178120,062,609194,929,409422,405,637155,321,874114,345,046168,106,984500,650,216756,709,758861,568,000
Net income
-38m
35,389,71563,587,32667,122,99382,640,76791,686,32654,429,11038,671,54547,253,53490,365,49415,671,67271,916,26236,843,2387,440,9300000-37,691,000
CFO
92m
-32.59%
14,643,90061,568,84450,330,56895,111,48774,020,36140,397,98469,323,57659,724,23916,375,405004,229,09922,750,88965,344,20818,367,22632,245,101137,022,06992,363,000
Dividend
Mar 23, 20151 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Rongyu Group Co., Ltd. engages in electrical equipment, credit investigation big data, and banking businesses in China. The company offers electrical equipment products, such as electronic control complete sets, permanent magnet low and high voltage switch products, and electronic energy meters, as well as automatic control system integration services; and credit investigation services. It also provides banking services comprising corporate finance, personal finance, and small and micro finance, as well as financial markets and international banking services; and equipment leasing, real estate leasing, and land use right leasing services. The company was formerly known as Jilin Yongda Group Co., Ltd. and changed its name to Rongyu Group Co., Ltd. in November 2016. Rongyu Group Co., Ltd. was founded in 1986 and is based in Beijing, China.
URL
http://www.wholeshinemedical.com/
IPO date
Oct 18, 2011
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT